Sonova Holding (OTCMKTS:SONVY) Given Average Recommendation of “Moderate Buy” by Brokerages

Shares of Sonova Holding (OTCMKTS:SONVY) have been given a consensus rating of “Moderate Buy” by the eight brokerages that are covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation, one has issued a buy recommendation and two have assigned a strong buy recommendation to the company.

Several equities research analysts recently issued reports on the company. Jefferies Financial Group downgraded Sonova from a “hold” rating to a “moderate sell” rating in a report on Wednesday. BNP Paribas Exane raised shares of Sonova from a “strong sell” rating to a “strong-buy” rating in a report on Tuesday, March 10th. Finally, Zacks Research upgraded shares of Sonova from a “strong sell” rating to a “hold” rating in a research note on Monday, February 9th.

Sonova Stock Down 0.5%

Shares of Sonova stock opened at $45.66 on Friday. Sonova has a 52 week low of $45.13 and a 52 week high of $68.76. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.24 and a quick ratio of 0.91. The business has a 50 day moving average price of $52.20 and a 200-day moving average price of $53.36.

About Sonova

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.